Global Rabies Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Rabies Diagnostics Market Growth (Status and Outlook) 2023-2029

Rabies is a viral disease that causes inflammation of the brain in humans and other mammals. Early symptoms can include fever and tingling at the site of exposure. These symptoms are followed by one or more of the following symptoms: violent movements, uncontrolled excitement, fear of water, an inability to move parts of the body, confusion, and loss of consciousness. Once symptoms appear, the result is nearly always death. The time period between contracting the disease and the start of symptoms is usually one to three months, but can vary from less than one week to more than one year. The time depends on the distance the virus must travel along peripheral nerves to reach the central nervous system.

LPI (LP Information)' newest research report, the “Rabies Diagnostics Industry Forecast” looks at past sales and reviews total world Rabies Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Rabies Diagnostics sales for 2023 through 2029. With Rabies Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rabies Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Rabies Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rabies Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rabies Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rabies Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rabies Diagnostics.

The global Rabies Diagnostics market size is projected to grow from US$ 1701.5 million in 2022 to US$ 2035.5 million in 2029; it is expected to grow at a CAGR of 2.6% from 2023 to 2029.

United States market for Rabies Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Rabies Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Rabies Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Rabies Diagnostics players cover Bio-Rad Laboratories, Merck, Thermo Fisher, Roche, BioMerieux, QIAGEN, Agilent, Creative Diagnostics and Techne, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Rabies Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Enzyme-Linked Immunosorbent Assay (ELISA)
Polymerase Chain Reaction (PCR) Assay
Others

Segmentation by application
Hospitals
Diagnostic Centers
Public Health Labs
Home Care Setting

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Merck
Thermo Fisher
Roche
BioMerieux
QIAGEN
Agilent
Creative Diagnostics
Techne
Fluidigm
Abbexa Ltd
BioNote, Inc
Norgen Biotek Corp
Aviva Systems Biology
Demeditec Diagnostics GmbH
Express Biotech International

Please note: The report will take approximately 2 business days to prepare and deliver.